Bonus Episode: IAS 2023 Conference HighlightsDr. William Short and Dr. Laura Armas-Kolostroubis join Bruce to talk about the research coming out of the 12th IAS Conference on HIV Science that took place July 23-26, 2023. They discuss some of the groundbreaking studies presented at the conference and how the research can be translated into clinical practice. They talk about research on zero transmission, studies looking at the next steps in long-acting technologies, and findings from a clinica...
All content for The Academy Exchange: HIV Today & Tomorrow is the property of American Academy of HIV Medicine and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Bonus Episode: IAS 2023 Conference HighlightsDr. William Short and Dr. Laura Armas-Kolostroubis join Bruce to talk about the research coming out of the 12th IAS Conference on HIV Science that took place July 23-26, 2023. They discuss some of the groundbreaking studies presented at the conference and how the research can be translated into clinical practice. They talk about research on zero transmission, studies looking at the next steps in long-acting technologies, and findings from a clinica...
Heterosexual women are not the typical demographic that is targeted in HIV research and treatments. But their risk factors for HIV are different and require unique methods to address. Bruce and clinical HIV Specialist™ Dr. William R. Short discuss the needs of women and HIV with a focus on women who are pregnant or may become pregnant. For more information about the Antiretroviral Pregnancy Registry, visit http://www.apregistry.com/.About Dr. Short:...
The Academy Exchange: HIV Today & Tomorrow
Bonus Episode: IAS 2023 Conference HighlightsDr. William Short and Dr. Laura Armas-Kolostroubis join Bruce to talk about the research coming out of the 12th IAS Conference on HIV Science that took place July 23-26, 2023. They discuss some of the groundbreaking studies presented at the conference and how the research can be translated into clinical practice. They talk about research on zero transmission, studies looking at the next steps in long-acting technologies, and findings from a clinica...
